
Intuitive Surgical ISRG
Quarterly report 2026-Q1
added 04-22-2026
Country |
|
IPO year |
2000 |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
357 M |
Market Cap[1] |
$ 149 B |
EBITDA (LTM) |
$ 2.95 B |
P/E (LTM) |
55.86 |
P/S (LTM) |
16.16 |
EPS (LTM) |
8.08 |
Intuitive Surgical is an American company that designs and manufactures surgical robots and related software. The company was founded in 1995 and is headquartered in Santa Clara, California.
Intuitive Surgical is a leader in the field of surgical robotics and provides its products in more than 60 countries around the world. Its main product, the Da Vinci system, allows surgeons to perform complex surgeries with high precision and minimal impact on the patient's body.
The company actively invests in research and development of new technologies to improve its products and expand its range. It also provides training and support for surgeons using its systems.
Intuitive Surgical adheres to high standards of quality and safety, and strives to improve the accessibility of its products to more patients around the world. The company continues to grow and develop to remain a leader in the field of surgical robotics and help people worldwide.
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
The Cooper Companies
COO
|
$ 68.2 | -0.61 % | $ 13.6 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Glaukos Corporation
GKOS
|
$ 122.5 | -3.04 % | $ 7.01 B | NYSE,SPB | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Alcon
ALC
|
$ 66.68 | -1.8 % | $ 40.4 B | NYSE | ||
|
ICU Medical
ICUI
|
$ 143.17 | 0.82 % | $ 3.53 B | Nasdaq Global Select Market,SPB | ||
|
iRhythm Technologies
IRTC
|
$ 115.19 | 1.19 % | $ 3.69 B | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 3.97 | -0.74 % | $ 183 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
LeMaitre Vascular
LMAT
|
$ 94.48 | -2.18 % | $ 2.14 B | Nasdaq Global Market,SPB | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Masimo Corporation
MASI
|
$ 179.95 | - | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Microbot Medical
MBOT
|
$ 1.8 | -1.1 % | $ 82.4 M | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Milestone Scientific
MLSS
|
$ 0.39 | 1.28 % | $ 32 M | NYSE American | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Merit Medical Systems
MMSI
|
$ 67.52 | 0.01 % | $ 3.99 B | Nasdaq Global Select Market,SPB | ||
|
electroCore
ECOR
|
$ 10.0 | 5.04 % | $ 84.8 K | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 24.56 | -0.12 % | $ 4.13 B | NYSE | ||
|
Haemonetics Corporation
HAE
|
$ 79.53 | 1.04 % | $ 3.75 B | NYSE,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
STERIS plc
STE
|
$ 209.56 | -1.56 % | $ 20.6 B | NYSE,SPB | ||
|
STAAR Surgical Company
STAA
|
$ 29.8 | -0.23 % | $ 1.48 B | Nasdaq Global Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 8.88 | -1.66 % | $ 183 M | NYSE American | ||
|
Teleflex Incorporated
TFX
|
$ 135.45 | -0.22 % | $ 6.04 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 68.56 | 0.72 % | $ 222 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 331.45 | -0.96 % | $ 24 B | NYSE,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 25.2 | -2.21 % | $ 1.7 B | Nasdaq Global Select Market | ||
|
DENTSPLY SIRONA
XRAY
|
$ 10.33 | -1.3 % | $ 2.06 B | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.69 | -0.13 % | $ 20.7 M | NYSE American | ||
|
Pro-Dex
PDEX
|
$ 63.68 | -2.03 % | $ 209 M | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
BioLife Solutions
BLFS
|
$ 27.09 | -1.67 % | $ 1.29 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.85 | -0.27 % | $ 168 M | NYSE American | ||
|
Baxter International
BAX
|
$ 20.62 | 2.95 % | $ 10.6 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 195.39 | -0.79 % | $ 28.5 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 27.27 | -0.13 % | $ 1.3 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 6.3 | 4.3 % | $ 280 M | Nasdaq Global Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
AngioDynamics
ANGO
|
$ 12.41 | 0.53 % | $ 507 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 150.4 | -1.08 % | $ 43.3 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 3.24 | -0.46 % | $ 34.4 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 4.12 | -2.95 % | $ 303 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 133.2 | 2.36 % | $ 7.49 M | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.